Oragenics Inc. Files 8-K Report
Ticker: OGEN · Form: 8-K · Filed: Apr 9, 2025 · CIK: 1174940
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: ORGN
TL;DR
ORGN filed an 8-K, mostly procedural stuff, check for exhibits.
AI Summary
On April 9, 2025, Oragenics, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided text. The company is incorporated in Florida and its principal executive offices are located in Sarasota, FL.
Why It Matters
This 8-K filing indicates that Oragenics, Inc. has submitted a regulatory report to the SEC, which may contain updates on company events or financial information.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report with no immediately apparent negative or positive material events disclosed in the provided text.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- April 9, 2025 (date) — Date of Report
- Sarasota, FL (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Oragenics, Inc.?
The filing is primarily for 'Other Events' and 'Financial Statements and Exhibits', indicating a routine submission of company information and potentially related documents.
When was this 8-K report filed by Oragenics, Inc.?
The report was filed on April 9, 2025.
Where are Oragenics, Inc.'s principal executive offices located?
The principal executive offices of Oragenics, Inc. are located at 1990 Main Street, Suite 750, Sarasota, FL 34236.
What is Oragenics, Inc.'s IRS Employer Identification Number?
Oragenics, Inc.'s IRS Employer Identification Number is 59-3410522.
What is the Standard Industrial Classification (SIC) code for Oragenics, Inc.?
The Standard Industrial Classification code for Oragenics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2025 regarding ORAGENICS INC (OGEN).